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WHAT THIS PAPER ADDS
 Critical hand ischaemia (CHI) due to pure below-the-elbow (BTE) artery obstruction is an emerging problem in end-stage-renal-
disease patients. This study assessed the feasibility, safety and outcomes of percutaneous transluminal angioplasty in this setting.
Its main ﬁndings are: 1) angioplasty of BTE arteries is feasible and safe, and the technical success rate was 82%; 2) the hand-healing
rate was lower (65%), mainly because of poor distal run-off; and 3) the clinically driven restenosis rate was low and the procedure
safely repeated.
 We believe that angioplasty is a promising ﬁrst-step approach to BTE vessel revascularisation.a r t i c l e i n f o
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Background: Critical hand ischaemia (CHI) due to pure below-the-elbow (BTE) artery obstruction is
a disabling disease and there is still no consensus concerning the most appropriate revascularisation
strategy. The aim of this study was to assess the feasibility, safety and outcomes of percutaneous
transluminal angioplasty (PTA) in the treatment of CHI due to pure BTE artery disease.
Methods and results: Twenty-eight patients (age 62  11 years; three females) with a total of 34 hands
affected by CHI (one pain at rest; 18 non-healing ulcer; 15 gangrene) due to pure BTE artery disease
underwent PTA. Most of the patients were males with a long history of diabetes mellitus, end-stage renal
disease (ESRD) on haemodialysis and systemic atherosclerosis. The interosseous artery was free of
disease in all cases, whereas the radial and ulnar arteries were simultaneously involved in 31/34 hands
with long stenosis/occlusions (91%; mean length 155  64 mm). The technical success rate was 82% (28/
34), with only three minor complications. In the three cases with a functioning radial arteriovenous
ﬁstula, we successfully treated the ulnar artery. PTA was unsuccessful in 18% (6/34) hands due to inability
to cross severely calciﬁed lesions. The hand-healing rate was 65% (22/34). The predictors of hand healing
were PTA technical success (odds ratio (OR) 0.5, conﬁdence interval (CI) 0.28e0.88; p  0.0001) and
digital run-off (OR 0.37, CI 0.19e0.71; p  0.003).
The mean follow-up period was 13  9 months. Six patients (18%) underwent secondary procedures due
to symptomatic restenosis. In all these cases, a successful re-PTAwas performed at a mean 6 months after
the index procedure, and there were no major procedure-related events. Ten patients (36%) died during
follow-up.
Conclusions: Angioplasty of BTE vessels for CHI is a feasible and safe procedure with acceptable rates of
technical success and hand healing. Poor digital run-off due to obstructive disease of the digital vessels
can reduce the hand-healing rate after a successful PTA. Pure isolated BTE vessel disease seems to
characterise patients with ESRD and diabetes mellitus.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.x: þ39 02 23933050.
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Table 2
Baseline angiographic data.
n %
No. of hands 34 100
Diseased artery
Radial 32 94
Focal stenosis 3 9
Diffuse stenosis 9 28
CTO 20 63
Ulnar 33 97
Focal stenosis 0 0
Diffuse stenosis 5 15
CTO 28 85
Interosseous 0 0
BTE disease
1-vessel(radial or ulnar) 3 9
2-vessel(radial þ ulnar) 31 91
Ipsilateral active AVF 3 9
Ipsilateral occluded AVF 7 21
No ipsilateral AVF 24 70
Digital run-off (0e9) score
0 1 3
1 3 9
2 2 6
3 3 9
4 5 15
5 3 9
6 6 18
7 4 12
8 5 15
9 2 6
CTO: chronic total occlusion; BTE: below-the-elbow; AVF: arteriovenous ﬁstula.
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rial disease is an uncommon condition, potentially disabling
because of its effect on hand function.1 Patients with CHI generally
present with pain, ulcerations, tissue necrosis and/or gangrene of
the ﬁngers. CHI may be caused by obstruction of the upper limb
arteries at different levels: above-the-elbow (ATE) arteries
(innominate, subclavian, axillary and humeral) and below-the-
elbow (BTE) arteries (radial, ulnar, interosseous and hand arteries).2
Percutaneous transluminal angioplasty (PTA) is now considered
a ﬁrst-line therapy for ATE artery disease,3,4 but there are few data
regarding the treatmentof BTE arteries.5e9 PTAof BTE arteries is useful
in patients with end-stage-renal-disease (ESRD) on haemodialysis
(HD)whopresent impaired arteriovenousﬁstula (AVF) functiondue to
inﬂow stenoses of the AVF-related artery,10e12 and there are a fewcase
reports of BTE vessel PTA for the treatment of CHI due to non-AVF-
related artery stenoses or diffuse BTE vessel disease.13e20
The aim of this study was to assess the feasibility, safety and
outcomes of PTA in treating CHI due to occlusive BTE artery disease.
Methods
Study population
All of the patients undergoing BTE-PTA as ﬁrst-step treatment
for CHI at Istituto Clinico Città Studi and Ospedale Maggiore Poli-
clinico (Milan, Italy) were prospectively enrolled between March
2004 and October 2010. The inclusion criteria were: 1) pain at rest
and/or ischaemic hand lesions (ﬁnger gangrene or ulceration); 2)
the absence of any critical lesion in the ATE arteries (50% diameter
stenosis) upon Doppler ultrasonography (US) examination; 3) the
presence of haemodynamic signiﬁcant BTE artery lesions, deﬁned
as a 50% diameter stenosis or occlusion involving the radial, ulnar
or interosseous artery (the distal arches originating from the radial
or ulnar arteries were considered part of these arteries). The
presence of an active or occluded ipsilateral AVF was recorded. The
exclusion criteria were ischaemia due to non-atherosclerotic
diseases, such as embolic disease treated by thrombolysis orTable 1
Baseline clinical characteristics.
n %
No. of patients 28
No. of hands 34
Mean age  SD (years) 62  11
Females 3 11
Smokers 12 43
Hypertension 20 71
Hyperlipidaemia 19 68
Diabetes 23 82
IDDM 21 75
Mean time from diagnosis  SD (years) 19.4  7.5
ESRD 25 89
Hemodialysis 22 79
Peritoneal dialysis 3 11
Mean time on dialysis  SD (years) 4.4  3.7
Previous renal transplantation 1 4
History of stroke 6 21
History of CAD 19 68
History of lower limb PAD 24 86
Minor amputation 9 32
Major amputation 14 50
Hand symptom/lesion
Pain at rest 1 3
Non-healing ulcer 18 53
Gangrene 15 44
Onset of clinical symptoms  SD (months) 3.8  2.5
IDDM: insulin-dependent diabetes mellitus; ESRD: end-stage renal disease; SD:
standard deviation; CAD: coronary artery disease; PAD: peripheral artery disease.embolectomy, connective tissue disorders, trauma, radiation and
thoracic outlet syndrome. The study was approved by our institu-
tional review committee and all the patients signed the informed
consent form of our hospital.
Procedural technique
Before revascularisation all the patients received local wound
care, antibiotics as indicated by wound cultures and double anti-
platelet therapy with aspirin (100 mg per day) and clopidogrel (a
300-mg loading dose followed by 75 mg per day).
The PTA procedures were performed under local anaesthesia by
antegrade brachial approach using a short 4-F sheath. Optimal
imaging of the vessel tree was obtained using iodixanol (Visipaque
320, GE Healthcare, NJ, USA), digital subtraction angiography and
magniﬁed antero-posterior hand projection. Heparin was routinely
administered intra-arterially to maintain activated clotting time
>25000. A 0.01400 wire (PT2, Boston Scientiﬁc, MA, USA) was used to
cross the lesions. Chronic total occlusions (CTOs) were crossedTable 3
Procedural data.
n %
No. of hands 34 100
Treated arteries (lesions) 38
Radial PTA 21 55
Ulnar PTA 17 45
Procedural time (mean  SD, minutes) 54  13
Dye amount (mean  SD, mL) 85  35
Rotablator 2 5
Stenosis pre-PTA (mean  SD) 96  6
Stenosis post-PTA (mean  SD) 5  11
Lesion length (mean  SD, mm) 153  64
Balloon diameter (mean  SD, mm) 2.5  0.3
Balloon inﬂation (mean  SD, atm) 15  2
Stent 2 6
Technical PTA success 28 82
PTA: percutaneous transluminal angioplasty; SD: standard deviation.
Figure 1. Successful angioplasty with good digital run-off. Patient FN: 69-year-old male with ESRD on HD. A: Baseline angiogram: occlusion of the ulnar artery, diffuse disease with
short occlusion of dominant radial artery; good patency of hand vessels. B: Final angiogram: eight patent digital vessels.
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Asahi, Japan), supported by over-the-wire balloons. No subintimal
approachwas used. If the balloonwas unable to cross the lesion, the
0.01400 wire was exchanged with a 0.00900 wire and a Rotablator
burr (diameter 1.25 mm) was advanced through the calciﬁcFigure 2. Successful angioplasty with good digital run-off. Patient FA: 54-year-old male with
diffuse radial artery disease. B, C: Balloon inﬂation through the palmar arch (radial-ulnar lostenosis at a mean rotational speed of 160,000 rpm. Small proﬁle
balloons (Amphirion Deep, Medtronic Invatec, Italy) were inﬂated
up to 12e16 atm for 2 min. The balloon size was selected on the
basis of vessel diameter and lesion length. FromMarch 2009, drug-
coated balloons (In.Pact Amphirion, Medtronic Invatec, Italy) weretype 2 diabetes and ESRD on HD. A: Baseline angiogram: occlusion of the ulnar artery,
op technique). D: Final angiogram: seven patent digital vessels.
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very painful, to prevent pain lidocaine 100 mg was administered
intra-arterially immediately before balloon inﬂation.21 Haemo-
stasis was obtained by manual compression.
Elective surgery (gangrenous phalanx and ﬁnger amputation)
was performed within 1 week. All the patients received double
anti-platelet therapy for 1 month (aspirin 100 mg and clopidogrel
75 mg per day); the treatment was not interrupted when surgical
procedures were undertaken.
Deﬁnitions and follow-up
PTA technical success was deﬁned as successful wire and
balloon crossing and dilatation till the palmar arch, with a ﬁnal
residual stenosis diameter of<30%. To describe run-off score (grade
0e9) we used a modiﬁed digital obstruction index22 giving one
point for each patent digital artery in the ﬁnal angiogram. Hand
healing was deﬁned as the absence of pain, ulcer healing and/or
surgical wound healing after necrotic tissue amputation. Follow-up
information was obtained by means of clinic visits. US was notFigure 3. Successful angioplasty of the non AVF-related artery. Patient AL: 52-year-old mal
artery, patent radial artery with functioning distal AVF. B: Balloon inﬂation (Anphirion Deep
eight patent digital vessels. D: Baseline lesion: second ﬁnger apical necrosis. E: Three monconsidered for screening: control angiography and re-PTA were
performed only in case of recurrent ischaemia.
Statistical analysis
Descriptive statistics were computed for all of the potential
covariates. The categorical variables were described by means of
numbers and percentages, and analysed using Fisher’s exact test.
The continuous variables were described using mean values and
their standard deviation (SD), and compared using Student’s t-test
if they were normally distributed or Wilcoxon’s rank-sum test if
they were not. Univariate logistic regression analyses were used to
identify the contribution of each relevant variable associated with
hand healing and technical success. All of the statistical tests were
two-tailed, and a p-value of 0.05 was considered statistically
signiﬁcant. The data were analysed using SPSS for Windows soft-
ware, release 15.0 (SPSS Inc., Chicago, IL, USA). Given the sample
size and total number of events, we did not make a multivariate
analysis and so the results should only be considered hypothesis
generating.e with type 1 diabetes and ESRD on HD. A: Baseline angiogram: occlusion of the ulnar
, Medtronic Invatec): diameter 2.5e3.0, conic, 21 cm long, 15 atm. C: Final angiogram:
ths later: complete healing.
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Population
The study involved 28 patients (mean age 62  11 years, three
females) and 34 hands with CHI. Table 1 shows the baseline clinical
data. The patients weremainly males with a long history of insulin-
dependent diabetes mellitus and ESRD.
Baseline angiographic data
Table 2 shows the baseline angiographic data. The interosseous
artery was disease free in all cases, 91% of which simultaneously
involved the radial and ulnar arteries. Three cases had an active
ipsilateral radiocephalic AVF associated with a CTO of the ulnar
artery; seven patients had an ipsilateral (four brachiocephalic, three
radiocephalic) previously occluded AVF at a mean time of 5.5  3.3
months. No angiographic lesions attributable to AVF surgery were
found in the brachial artery. Patients with previously occluded
radiocephalic AVF presented disease involving the proximal
segment of the radial artery.Figure 4. Successful angioplasty with poor digital run-off. Patient SR: 61-year-old male wit
artery disease; no visualization of digital vessels. B: Final angiogram: only one patent vesse
progression of gangrene with multiple ﬁnger amputations.Procedural data
Table 3 shows the procedural data. Thirty-eight arteries/lesions
were treated, generally long occlusions (mean length: 155 mm);
balloons with a mean diameter of 2.5 mmwere used. The technical
success rate was 82% (28/34 hands, Figs. 1e4); PTA was unsuc-
cessful in 6/34 (18%) hands due to inability to cross severely calci-
ﬁed lesions (Fig. 5). In the three cases with a functioning radial AVF,
we successfully treated the ulnar artery (Fig. 3). There were three
minor complications (8.8%): one radial artery perforation sealed by
means of prolonged balloon inﬂation and two ﬂow-limiting
dissections of the radial artery successfully treated with nitinol
self-expandable stents (X-Pert, Abbott, USA).
Eighteen patients with non-healing ulcers received local
debridement and daily dressing; in the 15 patients with gangrene,
nine ﬁngers and 14 phalanxes were amputated.
Short-term clinical outcomes
The hand-healing rate was 65% (22/34 hands) and the mean
healing time was 2  1.5 months. Univariate analysis showed thath type 1 diabetes and ESRD on HD. A: Baseline angiogram: extensive radial and ulnar
l in the ﬁrst ﬁnger. C: Baseline lesion: third ﬁnger gangrene. D: Twelve months later:
Figure 5. Uncrossable CTO. Patient FS. 38-year-old female with type 1 diabetes and ESRD in HD. A: Baseline radiogram: severe calciﬁcation of hand vessels extending to the digital
vessels. B: Baseline angiogram: occlusion of the distal radial artery and diffuse distal ulnar artery disease; only one patent digital vessel. The radial and ulnar artery lesions could not
be crossed by wires and balloons.
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ratio (OR) 0.5, conﬁdence interval (CI) 0.28e0.88; p  0.0001) and
digital run-off (OR 0.37, CI 0.19e0.71; p  0.003). The hand did not
heal in any of the patients undergoing an unsuccessful PTA, and in
6/28 (21%) of the patients with a successful PTA (Fig. 6). In the 12
non-healing patients, tissue loss remained stable in 8/12 and
developed extensive tissue involvement in 4/12 requiring further
multiple ﬁnger amputation (Fig. 4).Follow-up
Table 4 shows follow-up data. The mean follow-up period was
13  9 months. The recurrent ischaemia rate was 18%; one patientFigure 6. Hand healing rates in patients undergoing successful versus unsuccessful
angioplasty.had recurrent ischaemia twice. In all these cases, a successful re-
PTA was performed at 6 months after the index procedure, and
therewere nomajor procedure-related events. All the patients with
recurrent ischaemia healed after the repeat procedure. Ten patients
(36%) died during follow-up.Discussion
Ours is the ﬁrst study of a large series of unselected consecutive
patients with CHI due to pure atherosclerotic BTE artery disease
treated with PTA. Its main ﬁndings are as follows: 1) PTA of BTE
arteries is feasible and safe with a technical success rate acceptably
high (82%); 2) the hand-healing rate was lower (65%), because
diffuse disease extending to the ﬁnger arteries led to a poor digitalTable 4
Outcomes and follow-up data.
n %
No. of patients 28
No. of hands 34
Mean FU (mean  SD, months) 13  9
Procedure-related MACE 0 0
Death 10 36
Cardiac 5 18
Other 5 18
Recurrent ischemia 6 18
Re-PTA 6 18
TVR 6 18
Re-PTA time from index procedure (mean  SD, months) 6  3
Re-PTA success 6 100
FU: follow-up; MACE: major adverse cardiac event; PTA: percutaneous transluminal
angioplasty; TVR: target vessel revascularisation; SD: standard deviation.
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procedure could be safely repeated.
Size of the problem and pattern of disease
The true incidence of CHI due to BTE artery disease is difﬁcult to
assess because most patients are treated conservatively and rarely
identiﬁed. Most of the available data come from unselected patient
cohorts with different aetiological backgrounds and ATE and/or BTE
artery involvement.22e25 Recent data underline the fact that
signiﬁcant BTE artery stenoses are common in dialysis patients
with symptoms of hand ischaemia or vascular access dys-
function.26e28 Furthermore, distal calciﬁc arteriopathy may play
a pivotal role in causing hand ischaemia.28,29
Our patients had high rates of coronary artery disease (CAD)
(68%) and peripheral artery disease (PAD) (86%), and half of them
had undergone major lower limb amputation; mortality during
follow-up was also very high, as reported by other authors.7 These
data reinforce the idea that BTE vessel disease is an extreme
expression of widespread atherosclerotic disease. The longer
survival of ESRD patients suggests that CHI due to BTE vessel
disease may become a frequent problem in the near future.
Technical and clinical outcomes
Antegrade brachial approach, 4-F short sheaths, 0.01400 guide-
wires and long, thin proﬁle, 0.01400 compatible balloons are
essential for a safe and successful procedure. Micro-catheters,
rotablator, retrograde recanalisation and the palmar-arch-loop
technique17 can be used when necessary. Despite the extensive
occlusive BTE artery disease, the technical success rate was high
(82%), and the only failures were due to the impossibility of
crossing severely calciﬁed lesions. The hand-healing rate was 65%:
the hand did not heal in any of the patients undergoing an
unsuccessful procedure, and in 21% of the patients with a successful
PTA. Digital vessel run-off score, the expression of the extent of
occlusive disease in digital vessels, conditions the clinical result of
a technically successful PTA. Interestingly, our ﬁndings are similar
to those of Brosi et al., who observed that the efﬁcacy of BTE
angioplasty in patients with ESRD was limited by severely diseased
pedal arteries.30 The complication rate is so low that the procedure
can be very safely repeated.
Special attention was given to the presence of an active AVF. In
such cases, the possibility of treating a stenotic non-AVF-related
artery is a concrete option for reducing or abolishing hand
ischaemia, thus sparing the AVF for further dialysis.
Comparison with historical data
It is almost impossible to compare our ﬁndings with historical
data for a number of reasons. Only very few cases of PTA for BTE
vessels have been described10e20 and, in terms of surgery, only
a few descriptions of upper limb arterial reconstructions have been
published.4e8
Autogenous vein bypass from the brachial artery to the distal
radial or ulnar artery at the level of the wrist or proximal hand
requires good distal vessel patency and a reasonable run-off to the
superﬁcial or deep palmar arch, which is essential for maintaining
a successful bypass.9 This treatment option implies previous
patient selection and the exclusion of those with ‘non-recon-
structable disease’.7 Three other treatment alternatives have been
proposed for such patients: arterialising the venous system of the
hand;31 a distal bypass to the digital arteries;32 and thoracoscopic
sympathectomy.33 However, these strategies are limited to veryfew patients, generally without atherosclerotic disease and/or
ESRD.
Our data show that BTE arteries can be successfully treated up to
the palmar arch even in some cases of surgical ‘unreconstruct-
ability’ (Figs. 2e4). The clinically driven restenosis rate is low, and
repeat procedures are efﬁcacious. We therefore believe that BTE-
PTA is a promising ﬁrst-step approach to BTE vessel revascular-
isation. Lesson from our experience: if you get through the lesion
and you have good digital run-off you save the hand (and some-
times the ﬁstula).
Study limitations
The study was not randomised, and no independent core angi-
ography or US laboratories were involved. The referring centres for
our cathlabs are mainly diabetic foot clinics and nephrology
departments, which may explain the high prevalence of diabetes
and ESRD. Our patients were treated with uncoated and drug-
coated balloons, but numbers are too small to detect differences
between the two treatment options. Our patients underwent
a purely clinical follow-up, without any US or angiographic
assessment of vessel patency unless clinically driven, thus making
it impossible to detect any asymptomatic restenosis.
Conclusions
Angioplasty of BTE vessels for CHI is a feasible and safe proce-
dure that is characterised by acceptably high rates of technical
success and hand healing. The extension of obstructive disease to
the digital vessels leading to poor digital run-off can reduce the
hand-healing rate after a successful PTA. Pure isolated BTE vessel
disease seems to characterise patients with ESRD and diabetes
mellitus. Further studies are needed to conﬁrm our results.
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